Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 The Medicine Maker
Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 The Medicine Maker
Regenerative Medicine Market to Experience Significant Growth, Projected to Reach $183.08 Billion by 2031. openPR
1. Introduction In his worldwide best-seller Homo Deus [1], historian and philosopher Yuval Noah Harari discusses the future challenges facing humankind.
Stem-cell therapies that work: 10 Breakthrough Technologies 2025 MIT Technology Review
1st stem cell therapy, new HIV drug approved ecns
The transcription factor GABPA is a master regulator of naive pluripotency Nature.com
Abstract The terms MSC and MSCs have become the preferred acronym to describe a cell and a cell population of multipotential stem/progenitor cells commonly referred to as mesenchymal stem cells, multipotential stromal cells, mesenchymal stromal cells, and mesenchymal progenitor cells. The MSCs can differentiate to important lineages under defined conditions in vitro and in limited situations after implantation in vivo. MSCs were isolated and described about 30 years ago and now there are over 55,000 publications on MSCs readily available.
Science fiction turned reality? Stem cell therapy set to repair child's heart Ynetnews
See original here: Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
See the rest here: Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
Recent Comments